Evidence map›Paper›PMID 18818288›Full record

ArticleEndocrinology2009

Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets.

Pooya Jahanshahi, Runpei Wu, Jeffrey D Carter, Craig S Nunemaker

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Intravital Two-photon Imaging of CaScientific reports · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.American journal of physiology. Endocrinology and metabolism · 2014
    Article
  18. Review
  19. Article
  20. Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pooya JahanshahiDepartment of Medicine, Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA 22908-1413, USA.
Runpei Wu
Jeffrey D Carter
Craig S Nunemaker
University of Virginia · US

Funding

PILOT--PILOT/FEASIBILITY PROGRAMP30DK063609 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BARRETT, EUGENE JOSEPH · 2003 to 2007
$5.7M
Assessing and Improving Pancreatic Islet Viability and FunctionK01DK081621 · NIDDK · UNIVERSITY OF VIRGINIA · PI NUNEMAKER, CRAIG S · 2008 to 2010
$324k
NIDDK NIH HHS DK063609NIDDK NIH HHS K01 DK081621NIDDK NIH HHS P30 DK063609
6 · The paper itself

Abstract

Pulsatility is a fundamental feature of pancreatic islets and a hallmark of hormone secretion. Isolated pancreatic islets endogenously generate rhythms in secretion, metabolic activity, and intracellular calcium ([Ca(2+)](i)) that are important to normal physiological function. Few studies have directly compared oscillatory and nonoscillatory islets to identify possible differences in function. We investigated the hypothesis that the loss of these oscillations is a leading indicator of islet dysfunction by comparing oscillatory and nonoscillatory mouse islets for multiple parameters of function. Nonoscillatory islets displayed elevated basal [Ca(2+)](i) and diminished [Ca(2+)](i) response and insulin secretory response to 3-28 mm glucose stimulation compared with oscillatory islets, suggesting diminished glucose sensitivity. We investigated several possible mechanisms to explain these differences. No differences were observed in mitochondrial membrane potential, estimated ATP-sensitive potassium channel and L-type calcium channel activity, or cell death rates. Nonoscillatory islets, however, showed a reduced response to the sarco(endo)plasmic reticulum calcium ATPase inhibitor thapsigargin, suggesting a disruption in calcium homeostasis in the endoplasmic reticulum (ER) compared with oscillatory islets. The diminished ER calcium homeostasis among nonoscillatory islets was also consistent with the higher cytosolic calcium levels observed in 3 mm glucose. Inducing mild damage with low-dose proinflammatory cytokines reduced islet oscillatory capacity and produced similar effects on glucose-stimulated [Ca(2+)](i), basal [Ca(2+)](i), and thapsigargin response observed among untreated nonoscillatory islets. Our data suggest the loss of oscillatory capacity may be an early indicator of diminished islet glucose sensitivity and ER dysfunction, suggesting targets to improve islet assessment.

Indexed as

Drug ResistanceAnimalsBiological ClocksCalcium SignalingCytokinesDown-RegulationEndoplasmic ReticulumGlucoseIon Channel GatingIslets of LangerhansMaleMiceMitochondriaPeriodicityCytokinesGlucose

Identifiers

PMID18818288
PMCPMC2646533
OpenAlexW2135822167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.